A team of researchers at the University of California, Los Angeles (UCLA) has introduced a novel framework for monitoring ...
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the ...
This work presents an interactive graphics computational tool for the verification of prestressed concrete beams with post-tensioned bonded tendons to the serviceability limit state (SLS) stress check ...
Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 hot stocks to buy with the highest upside potential. On February 9, Sami Corwin from William Blair maintained a Buy rating on Beam Therapeutics.
Every now and then, a new brand pops up on our radar that we feel compelled to tell you about immediately. This isn’t one of those times, and Beams isn’t a new brand. It is, however, newly available ...